Correlation Between Candel Therapeutics and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Dermata Therapeutics, you can compare the effects of market volatilities on Candel Therapeutics and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Dermata Therapeutics.
Diversification Opportunities for Candel Therapeutics and Dermata Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Candel and Dermata is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Dermata Therapeutics
Given the investment horizon of 90 days Candel Therapeutics is expected to under-perform the Dermata Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Candel Therapeutics is 1.83 times less risky than Dermata Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Dermata Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 151.00 in Dermata Therapeutics on September 4, 2024 and sell it today you would lose (28.00) from holding Dermata Therapeutics or give up 18.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. Dermata Therapeutics
Performance |
| Timeline |
| Candel Therapeutics |
| Dermata Therapeutics |
Candel Therapeutics and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Dermata Therapeutics
The main advantage of trading using opposite Candel Therapeutics and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Dermata Therapeutics vs. Candel Therapeutics | Dermata Therapeutics vs. Cingulate Warrants | Dermata Therapeutics vs. Unicycive Therapeutics | Dermata Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |